Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salbutamol vs ipratropium bromide effect on airway dimensions in COPD (CT scan, crossover pilot)
2008-000609-12Phase 4Completed
- Sponsor
- Antwerp University Hospital
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of salbutamol and ipratropium bromide in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Antwerp University Hospital. Primary endpoint: Effect of delivery treatment on airway dimensions. Started May 2008; status: completed.
02
Drugs
salbutamolipratropium bromide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2008-000609-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000609-12.